Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Gastric Cancer

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 80 articles: HTML format

Single Articles

April 2021
1. OUYANG J, Xie Z, Lei X, Tang G, et al
   Clinical crosstalk between microRNAs and gastric cancer (Review).
   Int J Oncol. 2021;58:1.
   PubMed     Abstract available
   
   
   January 2021
2. BALI P, Lozano-Pope I, Pachow C, Obonyo M, et al
   Early detection of tumor cells in bone marrow and peripheral blood in a fastprogressing gastric cancer model.
   Int J Oncol. 2021 Jan 12. doi: 10.3892/ijo.2021.5171.
   PubMed     Abstract available
   
   
   September 2020
3. SUN Z, Gao X, Zabkiewicz C, Ruge F, et al
   Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
   Int J Oncol. 2020;57:813-824.
   PubMed     Abstract available
   
   
   May 2020
4. XU X, Xia Y, Ma J, Li W, et al
   Upregulation of miRNA301a3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NFkappaB signaling.
   Int J Oncol. 2020 May 26. doi: 10.3892/ijo.2020.5072.
   PubMed     Abstract available
   
   
   April 2020
5. LIU AG, Zhong JC, Chen G, He RQ, et al
   Upregulated expression of SAC3D1 is associated with progression in gastric cancer.
   Int J Oncol. 2020 Apr 15. doi: 10.3892/ijo.2020.5048.
   PubMed     Abstract available
   
   
   
6. YAMAKOSHI Y, Tanaka H, Sakimura C, Deguchi S, et al
   Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
   Int J Oncol. 2020 Apr 8. doi: 10.3892/ijo.2020.5042.
   PubMed     Abstract available
   
   
   February 2020
7. LONG B, Qin L, Zhang B, Li Q, et al
   CAR Tcell therapy for gastric cancer: Potential and perspective (Review).
   Int J Oncol. 2020 Feb 12. doi: 10.3892/ijo.2020.4982.
   PubMed     Abstract available
   
   
   December 2019
8. SUN T, Wang D, Ping Y, Sang Y, et al
   Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
   Int J Oncol. 2019 Dec 16. doi: 10.3892/ijo.2019.4944.
   PubMed     Abstract available
   
   
   November 2019
9. SZATANEK R, Weglarczyk K, Stec M, Baran J, et al
   Autologous tumorderived microvesicles influence gene expression profiles and enhance protumorigenic chemotactic potential, signal transduction and cellular respiration in gastric cancer cells.
   Int J Oncol. 2019 Nov 26. doi: 10.3892/ijo.2019.4923.
   PubMed     Abstract available
   
   
   September 2019
10. LI H, Wang C, Wei Z, Chen W, et al
    Differences in the prognosis of gastric cancer patients of different sexes and races and the molecular mechanisms involved.
    Int J Oncol. 2019 Sep 26. doi: 10.3892/ijo.2019.4885.
    PubMed     Abstract available
    
    
    August 2019
11. SHIOZAKI A, Yamazato Y, Kosuga T, Kudou M, et al
    Effect of low temperature on the regulation of cell volume after hypotonic shock in gastric cancer cells.
    Int J Oncol. 2019 Aug 2. doi: 10.3892/ijo.2019.4853.
    PubMed     Abstract available
    
    
    July 2019
12. LI J, Xi H, Guo X, Gao Y, et al
    Surgical outcomes and learning curve analysis of robotic gastrectomy for gastric cancer: Multidimensional analysis compared with threedimensional highdefinition laparoscopic gastrectomy.
    Int J Oncol. 2019 Jul 30. doi: 10.3892/ijo.2019.4851.
    PubMed     Abstract available
    
    
    
13. ALARCON-MILLAN J, Martinez-Carrillo DN, Peralta-Zaragoza O, Fernandez-Tilapa G, et al
    Regulation of GKN1 expression in gastric carcinogenesis: A problem to resolve (Review).
    Int J Oncol. 2019 Jul 16. doi: 10.3892/ijo.2019.4843.
    PubMed     Abstract available
    
    
    June 2019
14. DENG LM, Tan T, Zhang TY, Xiao XF, et al
    miR1 reverses multidrug resistance in gastric cancer cells via downregulation of sorcin through promoting the accumulation of intracellular drugs and apoptosis of cells.
    Int J Oncol. 2019 Jun 25. doi: 10.3892/ijo.2019.4831.
    PubMed     Abstract available
    
    
    
15. WANG W, Liu L, Zhou Y, Ye Q, et al
    Hydroxychloroquine enhances the antitumor effects of BC001 in gastric cancer.
    Int J Oncol. 2019 Jun 12. doi: 10.3892/ijo.2019.4824.
    PubMed     Abstract available
    
    
    
16. GAN L, Lv L, Liao S
    Long noncoding RNA H19 regulates cell growth and metastasis via the miR223p/Snail1 axis in gastric cancer.
    Int J Oncol. 2019;54:2157-2168.
    PubMed     Abstract available
    
    
    
17. WANG J, Yao Y, Zhang Q, Li S, et al
    Inflammatory responses induced by Helicobacter pylori on the carcinogenesis of gastric epithelial GES1 cells.
    Int J Oncol. 2019;54:2200-2210.
    PubMed     Abstract available
    
    
    April 2019
18. LU CC, Chiang JH, Tsai FJ, Hsu YM, et al
    Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling.
    Int J Oncol. 2019;54:1271-1281.
    PubMed     Abstract available
    
    
    March 2019
19. ZHI X, Li B, Li Z, Zhang J, et al
    Adrenergic modulation of AMPKdependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer.
    Int J Oncol. 2019 Mar 18. doi: 10.3892/ijo.2019.4753.
    PubMed     Abstract available
    
    
    
20. CHEN C, Tang X, Liu Y, Zhu J, et al
    Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Int J Oncol. 2019 Mar 18. doi: 10.3892/ijo.2019.4751.
    PubMed     Abstract available
    
    
    
21. FU R, Wang X, Hu Y, Du H, et al
    Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway.
    Int J Oncol. 2019 Mar 12. doi: 10.3892/ijo.2019.4744.
    PubMed     Abstract available
    
    
    February 2019
22. LI J, Feng D, Gao C, Zhang Y, et al
    Isoforms S and L of MRPL33 from alternative splicing have isoformspecific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway.
    Int J Oncol. 2019 Feb 27. doi: 10.3892/ijo.2019.4728.
    PubMed     Abstract available
    
    
    
23. AN C, Li H, Zhang X, Wang J, et al
    Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway.
    Int J Oncol. 2019 Feb 18. doi: 10.3892/ijo.2019.4717.
    PubMed     Abstract available
    
    
    January 2019
24. WANG S, Yao Y, Rao C, Zheng G, et al
    25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via the TLR2/NF-kappaB signaling pathway.
    Int J Oncol. 2019 Jan 11. doi: 10.3892/ijo.2019.4684.
    PubMed     Abstract available
    
    
    
25. JIAO Y, Yang H, Qian J, Gong Y, et al
    miR36645P suppresses the proliferation and metastasis of gastric cancer by attenuating the NFkappaB signaling pathway through targeting MTDH.
    Int J Oncol. 2019 Jan 8. doi: 10.3892/ijo.2019.4680.
    PubMed     Abstract available
    
    
    
26. SHU F, Zou X, Tuo H, She S, et al
    Stathmin gene silencing suppresses proliferation, migration and invasion of gastric cancer cells via AKT/sCLU and STAT3 signaling.
    Int J Oncol. 2019 Jan 3. doi: 10.3892/ijo.2019.4674.
    PubMed     Abstract available
    
    
    December 2018
27. HUANG L, Wang ZY, Pan DD
    Penicillinbinding protein 1A mutationpositive Helicobacter pylori promotes epithelialmesenchymal transition in gastric cancer via the suppression of microRNA134.
    Int J Oncol. 2018 Dec 12. doi: 10.3892/ijo.2018.4665.
    PubMed     Abstract available
    
    
    November 2018
28. MA C, Xie J, Luo C, Yin H, et al
    OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGFC expression and secretion.
    Int J Oncol. 2018 Nov 26. doi: 10.3892/ijo.2018.4648.
    PubMed     Abstract available
    
    
    
29. FANG Z, Zhong M, Wang Y, Yuan X, et al
    miR381 and miR489 suppress cell proliferation and invasion by targeting CUL4B via the Wnt/betacatenin pathway in gastric cancer.
    Int J Oncol. 2018 Nov 26. doi: 10.3892/ijo.2018.4646.
    PubMed     Abstract available
    
    
    
30. SONG Y, Wang R, Li LW, Liu X, et al
    Long non-coding RNA HOTAIR mediates the switching of histone H3 lysine 27 acetylation to methylation to promote epithelial-to-mesenchymal transition in gastric cancer.
    Int J Oncol. 2018 Nov 5. doi: 10.3892/ijo.2018.4625.
    PubMed     Abstract available
    
    
    
31. LIU F, Cheng L, Xu J, Guo F, et al
    miR-17-92 functions as an oncogene and modulates NF-kappaB signaling by targeting TRAF3 in MGC-803 human gastric cancer cells.
    Int J Oncol. 2018;53:2241-2257.
    PubMed     Abstract available
    
    
    
32. NGABIRE D, Seong YA, Patil MP, Niyonizigiye I, et al
    Induction of apoptosis and G1 phase cell cycle arrest by Aster incisus in AGS gastric adenocarcinoma cells.
    Int J Oncol. 2018;53:2300-2308.
    PubMed     Abstract available
    
    
    October 2018
33. YAN L, Zhang J, Guo D, Ma J, et al
    IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.
    Int J Oncol. 2018 Oct 31. doi: 10.3892/ijo.2018.4612.
    PubMed     Abstract available
    
    
    
34. XI Z, Si J, Nan J
    LncRNA MALAT1 potentiates autophagyassociated cisplatin resistance by regulating the microRNA30b/autophagyrelated gene 5 axis in gastric cancer.
    Int J Oncol. 2018 Oct 26. doi: 10.3892/ijo.2018.4609.
    PubMed     Abstract available
    
    
    
35. WANG M, Qiu R, Yu S, Xu X, et al
    Paclitaxelresistant gastric cancer MGC803 cells promote epithelialtomesenchymal transition and chemoresistance in paclitaxelsensitive cells via exosomal delivery of miR1555p.
    Int J Oncol. 2018 Oct 22. doi: 10.3892/ijo.2018.4601.
    PubMed     Abstract available
    
    
    
36. YAN R, Li K, Yuan DW, Wang HN, et al
    Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Int J Oncol. 2018 Oct 12. doi: 10.3892/ijo.2018.4595.
    PubMed     Abstract available
    
    
    
37. HUANG H, Tang J, Zhang L, Bu Y, et al
    miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1.
    Int J Oncol. 2018 Oct 11. doi: 10.3892/ijo.2018.4593.
    PubMed     Abstract available
    
    
    September 2018
38. CHUA PJ, Lim JP, Guo TT, Khanna P, et al
    Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells.
    Int J Oncol. 2018 Sep 11. doi: 10.3892/ijo.2018.4557.
    PubMed     Abstract available
    
    
    August 2018
39. CAO B, Zhao Y, Zhang Z, Li H, et al
    Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer.
    Int J Oncol. 2018 Aug 9. doi: 10.3892/ijo.2018.4519.
    PubMed     Abstract available
    
    
    June 2018
40. LI L, Cui Y, Ye L, Zhao Z, et al
    Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
    Int J Oncol. 2018 Jun 26. doi: 10.3892/ijo.2018.4455.
    PubMed     Abstract available
    
    
    
41. PEI L, He X, Li S, Sun R, et al
    KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Int J Oncol. 2018 Jun 19. doi: 10.3892/ijo.2018.4446.
    PubMed     Abstract available
    
    
    
42. HU C, Zhou Y, Liu C, Kang Y, et al
    A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Int J Oncol. 2018 Jun 6. doi: 10.3892/ijo.2018.4433.
    PubMed     Abstract available
    
    
    May 2018
43. OKUGAWA Y, Toiyama Y, Ichikawa T, Kawamura M, et al
    Colony-stimulating factor-1 and colony-stimulating factor-1 receptor co-expression is associated with disease progression in gastric cancer.
    Int J Oncol. 2018 May 16. doi: 10.3892/ijo.2018.4406.
    PubMed     Abstract available
    
    
    April 2018
44. WANG J, Liang WJ, Min GT, Wang HP, et al
    LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4356.
    PubMed     Abstract available
    
    
    March 2018
45. YU S, Li L, Wu Q, Dou N, et al
    PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.
    Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4329.
    PubMed     Abstract available
    
    
    February 2018
46. ZHOU D, Zhou Y, Li C, Yang L, et al
    Silencing of B7-H4 suppresses the tumorigenicity of the MGC-803 human gastric cancer cell line and promotes cell apoptosis via the mitochondrial signaling pathway.
    Int J Oncol. 2018 Feb 13. doi: 10.3892/ijo.2018.4274.
    PubMed     Abstract available
    
    
    
47. LU M, Huang Y, Sun W, Li P, et al
    miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
    Int J Oncol. 2018;52:589-598.
    PubMed     Abstract available
    
    
    
48. LI L, Yang D, Cui D, Li Y, et al
    Quantitative proteomics analysis of the role of tetraspanin-8 in the drug resistance of gastric cancer.
    Int J Oncol. 2018;52:473-484.
    PubMed     Abstract available
    
    
    January 2018
49. LIAN G, Li L, Shi Y, Jing C, et al
    BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells.
    Int J Oncol. 2018 Jan 25. doi: 10.3892/ijo.2018.4255.
    PubMed     Abstract available
    
    
    
50. FEI HJ, Chen SC, Zhang JY, Li SY, et al
    Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
    Int J Oncol. 2018 Jan 11. doi: 10.3892/ijo.2018.4243.
    PubMed     Abstract available
    
    
    
51. ARAI H, Wada R, Ishino K, Kudo M, et al
    Expression of DNA damage response proteins in gastric cancer: Comprehensive protein profiling and histological analysis.
    Int J Oncol. 2018 Jan 5. doi: 10.3892/ijo.2018.4238.
    PubMed     Abstract available
    
    
    December 2017
52. YAN H, Xiao F, Zou J, Qiu C, et al
    NR4A1-induced increase in the sensitivity of a human gastric cancer line to TNFalpha-mediated apoptosis is associated with the inhibition of JNK/Parkin-dependent mitophagy.
    Int J Oncol. 2017 Dec 4. doi: 10.3892/ijo.2017.4216.
    PubMed     Abstract available
    
    
    October 2017
53. WANG YM, Gu ML, Meng FS, Jiao WR, et al
    Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines.
    Int J Oncol. 2017 Oct 23. doi: 10.3892/ijo.2017.4176.
    PubMed     Abstract available
    
    
    
54. LIU Y, Zhang C, Zhao L, Du N, et al
    APPL1 promotes the migration of gastric cancer cells by regulating Akt2 phosphorylation.
    Int J Oncol. 2017;51:1343-1351.
    PubMed     Abstract available
    
    
    
55. ZHOU J, Wu X, Li G, Gao X, et al
    Prediction of radiosensitive patients with gastric cancer by developing gene signature.
    Int J Oncol. 2017;51:1067-1076.
    PubMed     Abstract available
    
    
    September 2017
56. WANG G, Huang YX, Zhang R, Hou LD, et al
    Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC7901 cells partly via miR200amediated downregulation of beta-catenin pathway.
    Int J Oncol. 2017 Sep 27. doi: 10.3892/ijo.2017.4139.
    PubMed     Abstract available
    
    
    
57. WEI F, Jiang X, Gao HY, Gao SH, et al
    Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo.
    Int J Oncol. 2017 Sep 22. doi: 10.3892/ijo.2017.4134.
    PubMed     Abstract available
    
    
    August 2017
58. PAN Z, Tian Y, Zhang B, Zhang X, et al
    YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.
    Int J Oncol. 2017 Aug 23. doi: 10.3892/ijo.2017.4101.
    PubMed     Abstract available
    
    
    July 2017
59. LEE H, Saini N, Parris AB, Zhao M, et al
    Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling.
    Int J Oncol. 2017 Jul 13. doi: 10.3892/ijo.2017.4073.
    PubMed     Abstract available
    
    
    
60. XU M, Qin S, Cao F, Ding S, et al
    MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Int J Oncol. 2017 Jul 12. doi: 10.3892/ijo.2017.4072.
    PubMed     Abstract available
    
    
    May 2017
61. KIM B, Kim YS, Ahn HM, Lee HJ, et al
    Peroxiredoxin 5 overexpression enhances tumorigenicity and correlates with poor prognosis in gastric cancer.
    Int J Oncol. 2017 May 19. doi: 10.3892/ijo.2017.4013.
    PubMed     Abstract available
    
    
    
62. DU Y, Jiang B, Song S, Pei G, et al
    Metadherin regulates actin cytoskeletal remodeling and enhances human gastric cancer metastasis via epithelial-mesenchymal transition.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4002.
    PubMed     Abstract available
    
    
    
63. XIAO S, Zhou L
    Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.4000.
    PubMed     Abstract available
    
    
    
64. GE L, Li DS, Chen F, Feng JD, et al
    TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells.
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3998.
    PubMed     Abstract available
    
    
    
65. ZHUANG K, Zhang L, Zhang X, Tang H, et al
    Gastrin induces multidrug resistance via the degradation of p27Kip1 in the gastric carcinoma cell line SGC7901.
    Int J Oncol. 2017 May 4. doi: 10.3892/ijo.2017.3983.
    PubMed     Abstract available
    
    
    
66. ZENG XQ, Wang J, Chen SY
    Methylation modification in gastric cancer and approaches to targeted epigenetic therapy (Review).
    Int J Oncol. 2017 May 3. doi: 10.3892/ijo.2017.3981.
    PubMed     Abstract available
    
    
    
67. FUJIWARA Y, Okada K, Omori T, Sugimura K, et al
    Multiple therapeutic peptide vaccines for patients with advanced gastric cancer.
    Int J Oncol. 2017;50:1655-1662.
    PubMed     Abstract available
    
    
    April 2017
68. PAN Y, Shu X, Sun L, Yu L, et al
    miR196a5p modulates gastric cancer stem cell characteristics by targeting Smad4.
    Int J Oncol. 2017 Apr 19. doi: 10.3892/ijo.2017.3965.
    PubMed     Abstract available
    
    
    
69. WANG R, Song Y, Liu X, Wang Q, et al
    UBE2C induces EMT through Wnt/betacatenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
    Int J Oncol. 2017;50:1116-1126.
    PubMed     Abstract available
    
    
    March 2017
70. HUANG T, Wang L, Liu D, Li P, et al
    FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1.
    Int J Oncol. 2017 Mar 22. doi: 10.3892/ijo.2017.3927.
    PubMed     Abstract available
    
    
    
71. WANG C, Yang C, Ji J, Jiang J, et al
    Deubiquitinating enzyme USP20 is a positive regulator of Claspin and suppresses the malignant characteristics of gastric cancer cells.
    Int J Oncol. 2017 Mar 8. doi: 10.3892/ijo.2017.3904.
    PubMed     Abstract available
    
    
    
72. NASSER MI, Masood M, Wei W, Li X, et al
    Cordycepin induces apoptosis in SGC7901 cells through mitochondrial extrinsic phosphorylation of PI3K/Akt by generating ROS.
    Int J Oncol. 2017;50:911-919.
    PubMed     Abstract available
    
    
    February 2017
73. SHEN L, Luo Z, Wu J, Qiu L, et al
    Enhanced expression of alpha2,3-linked sialic acids promotes gastric cancer cell metastasis and correlates with poor prognosis.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3882.
    PubMed     Abstract available
    
    
    
74. FUJIMOTO D, Goi T, Hirono Y
    Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
    Int J Oncol. 2017;50:448-456.
    PubMed     Abstract available
    
    
    December 2016
75. LEE JH, Kim SS, Lee HS, Hong S, et al
    Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3793.
    PubMed     Abstract available
    
    
    November 2016
76. LI R, Yang HQ, Xi HL, Feng S, et al
    Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells.
    Int J Oncol. 2016 Nov 28. doi: 10.3892/ijo.2016.3783.
    PubMed     Abstract available
    
    
    October 2016
77. XU M, Zhou H, Zhang C, He J, et al
    ADAM17 promotes epithelial-mesenchymal transition via TGF-beta/Smad pathway in gastric carcinoma cells.
    Int J Oncol. 2016 Oct 21. doi: 10.3892/ijo.2016.3744.
    PubMed     Abstract available
    
    
    September 2016
78. HUANG T, Wang-Johanning F, Zhou F, Kallon H, et al
    MicroRNAs serve as a bridge between oxidative stress and gastric cancer (Review).
    Int J Oncol. 2016 Sep 9. doi: 10.3892/ijo.2016.3686.
    PubMed     Abstract available
    
    
    August 2016
79. TANG C, Jiang Y, Shao W, Shi W, et al
    Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer.
    Int J Oncol. 2016 Aug 18. doi: 10.3892/ijo.2016.3661.
    PubMed     Abstract available
    
    
    
80. XIE P, Fujii I, Zhao J, Shinohara M, et al
    A novel polysaccharide derived from algae extract induces apoptosis and cell cycle arrest in human gastric carcinoma MKN45 cells via ROS/JNK signaling pathway.
    Int J Oncol. 2016 Aug 18. doi: 10.3892/ijo.2016.3658.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: